Investment Summary

HealthEdge Investment Partners Invests In Anodyne

On April 25, 2022, private equity firm HealthEdge Investment Partners invested in medical products company Anodyne

Investment Highlights
  • This is HealthEdge Investment Partners’ 3rd transaction in the Medical Products sector.
  • This is HealthEdge Investment Partners’ 21st transaction in the United States.
  • This is HealthEdge Investment Partners’ 2nd transaction in Wisconsin.

Investment Summary
Date 2022-04-25
Target Anodyne
Sector Medical Products
Investor(s) HealthEdge Investment Partners
Deal Type Growth Capital

Target

Anodyne

Milwaukee, Wisconsin, United States
Anodyne is a brand and foremost innovator of clinical footwear solutions aimed at the growing diabetic population. Anodyne was founded in 2015 and is based in Milwaukee, Wisconsin.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

HealthEdge Investment Partners

Tampa, Florida, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2005
Size Small
Type Sector Focused
DESCRIPTION

HealthEdge Investment Partners is an operating-oriented private equity firm that targets the healthcare industry. The firm pursues buyouts, recapitalizations or structured investments in healthcare companies with a strong market share. HealthEdge targets businesses with enterprise value ranging between $10 million and $100 million, and with revenues ranging between $5 million and $75 million. Moreover, the firm looks for companies with EBITDA near $15 million. The firm typically commits between $5 million to $20 million of capital per company. HealthEdge focuses on the healthcare segments that involve medical products, devices and equipment, healthcare services, healthcare IT, pharmaceutical, and distribution. HealthEdge Investment Partners was founded in 2005 and is based in Tampa, Florida.

DEAL STATS #
Overall 21 of 24
Sector (Medical Products) 3 of 4
Type (Growth Capital) 6 of 8
State (Wisconsin) 2 of 2
Country (United States) 21 of 24
Year (2022) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-11 SPNN

Sarasota, Florida, United States

SPNN is a nationwide nursing network that focuses on the therapy management of patients with rare, chronic disorders. SPNN professional staff consists of CRNI®, OCN®, IgCN®, PICC, and IV certified nurses who administer specialty pharmacy therapies to patients in the comfort of their home, physician offices, and ambulatory infusion centers (AIC). SPNN was founded in 2009 and is based in Sarasota, Florida.

Sell $60M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-12 CSS Health

Thonotosassa, Florida, United States

CSS Health combines Medicine-On-Time, the innovative multi-dose blister-pack drug compliance packaging for pharmacies, and Clinical Support Services, an independent Medication Therapy Management patient outreach platform for health plans, in a unique end-to-end adherence offering designed to help patients more effectively take their medications as directed. CSS Health was formed in 1999 and is based in Thonotosassa, Florida.

Sell -
Mergr

Product

Company

Legal